- Home
- VRNA vs MEOH Comparison
VRNA vs MEOH Comparison
Compare VRNA & MEOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- MEOH
- Stock Information
- Founded
- VRNA 2005
- MEOH 1968
- Country
- VRNA United Kingdom
- MEOH Canada
- Employees
- VRNA N/A
- MEOH N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- MEOH Major Chemicals
- Sector
- VRNA Health Care
- MEOH Industrials
- Exchange
- VRNA Nasdaq
- MEOH Nasdaq
- Market Cap
- VRNA 3.4B
- MEOH 3.3B
- IPO Year
- VRNA 2017
- MEOH N/A
- Fundamental
- Price
- VRNA $51.89
- MEOH $49.32
- Analyst Decision
- VRNA Strong Buy
- MEOH Buy
- Analyst Count
- VRNA 7
- MEOH 7
- Target Price
- VRNA $50.57
- MEOH $57.71
- AVG Volume (30 Days)
- VRNA 1.4M
- MEOH 338.6K
- Earning Date
- VRNA 02-27-2025
- MEOH 01-29-2025
- Dividend Yield
- VRNA N/A
- MEOH 1.50%
- EPS Growth
- VRNA N/A
- MEOH N/A
- EPS
- VRNA N/A
- MEOH 2.12
- Revenue
- VRNA $5,624,000.00
- MEOH $3,693,288,000.00
- Revenue This Year
- VRNA N/A
- MEOH $4.71
- Revenue Next Year
- VRNA $550.30
- MEOH $13.08
- P/E Ratio
- VRNA N/A
- MEOH $21.89
- Revenue Growth
- VRNA 1127.95
- MEOH N/A
- 52 Week Low
- VRNA $11.39
- MEOH $36.13
- 52 Week High
- VRNA $55.42
- MEOH $56.43
- Technical
- Relative Strength Index (RSI)
- VRNA 64.25
- MEOH 56.26
- Support Level
- VRNA $43.44
- MEOH $49.08
- Resistance Level
- VRNA $55.42
- MEOH $50.72
- Average True Range (ATR)
- VRNA 3.32
- MEOH 1.28
- MACD
- VRNA 0.40
- MEOH -0.10
- Stochastic Oscillator
- VRNA 70.52
- MEOH 51.04
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About MEOH Methanex Corporation
Methanex Corp manufactures and sells methanol. Methanex's customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. Methanex distributes its products through a global supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. China generates the most revenue of any geographical segment.